mglur2

(RS)-MCPG ((±)-MCPG) 是一种竞争性和选择性 I II 组代谢型谷氨酸受体 (mGluR) 拮抗剂，可阻断 TBS 诱导的幼年和新生大鼠海马神经元的转变。

Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) (LY2140023 hydrochloride) 是的 LY404039 的蛋氨酸前药，具有口服活性。LY404039是一种选择性 mGlu2 3 受体激动剂。Pomaglumetad methionil hydrochloride 可用于精神分裂症的研究。

EGLU ((2S)-α-Ethylglutamic acid) 是一种竞争性 mGluR-2 受体拮抗剂，具有抗抑郁活性和抗伤害作用，可用于研究关节炎。

AZD-8529 mesylate 是高度选择性的可口服mGluR2正向调节剂，EC50值为 285 nM。它在 20-25 M 时，对 mGluR1、3、4、5、6、7 和 8 亚型没有显示正变构调节剂反应。

MNI 137 是 mGlu2 的负变构调节剂。 MNI 137 抑制谷氨酸诱导的钙动员，对人和大鼠的 IC50 分别为 8.3 和 12.6 nM。

LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells.

Biphenylindanone A is a selective potentiator of human mGluR2 (hmGluR2),and for the treatment of neurological disorders.

Decoglurant (RO4995819) 是 mGluR2和 mGluR3的负变构调制器，有抗抑郁作用。

JNJ-46281222 is an metabotropic glutamate (mGlu) 2-selective, highly potent PAM (positive allosteric modulator). It has nanomolar affinity (Kd = 1.7 nM) and a high modulatory potency (pEC50 = 7.71).

LY2812223 is a highly effective and functionally selective mGlu2 receptor agonist. It has a mGlu2 binding affinity for mGlu2 and mGlu3 (Ki=144 nM and 156 nM, respectively).

CBiPES hydrochloride(CBiPES HCl) 是一种高效的 mGlu2 受体正变构调节剂，EC50值为 92.8 nM。CBiPES hydrochloride 可阻断 WT 和 mGlu（3） 受体的作用。CBiPES hydrochloride 可用于研究像癫痫和帕金森综合征类的神经系统疾病。

(S)-4CPG ((S)-4-Carboxyphenylglycine) 是一种竞争性 mGlu1 受体拮抗剂，可减轻大鼠与坐骨神经收缩损伤相关的痛觉过敏和痛觉异常，可用于研究神经性疾病。

JNJ-40411813 (ADX-71149) 是一种新型 mGlu2R 正变构调节剂，EC50 值为 147 nM。

mGluR2 modulator5 (Compound 11) 作为一种口服活性强的选择性 mGluR2 负向变构调节剂，其 IC50 值为 8.9 nM。该化合物在大鼠的药代动力学研究中显示能有效通过血脑屏障。mGluR2 modulator5 在神经疾病领域的研究中，尤其在调节情绪障碍相关的认知与神经功能方面，展现出应用潜力。

mGluR2 antagonist 1 is a potent and selective class of negative allosteric modulator targeting the metabotropic glutamate receptor 2 (mGluR2) with high oral bioavailability. It displays a remarkable affinity for mGluR2, with an IC50 value of 9 nM. Furthermore, it exhibits excellent permeability across the blood-brain barrier, making it a promising candidate for central nervous system-related studies or therapies.

mGluR2 modulator 2 (compound 2) 可用于抗精神病药物研究。mGluR2 modulator 2 是一种有效的、选择性和口服生物可利用的mGluR2正变构调节剂，EC50值为 0.13 μM。

mGluR2 modulator 4 (compound 47) is a highly potent positive allosteric modulator of mGluR2, exhibiting an EC 50 value of 0.8 μM. It holds the potential for investigating antipsychotic properties [1].

mGluR2 modulator 1 (compound 95) 是一种有效的、具有血脑屏障通透性的 mGluR2 (代谢型谷氨酸受体-2)正向变构调节剂 (EC50: 0.03 μM)。mGluR2 modulator 1 能够用于研究精神病。

AZD-8529 is a highly selective, and orally bioavailable positive allosteric modulator of mGluR2 (EC50: 285 nM). It shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.

LY3020371 hydrochloride exerts an antidepressant-like signature in vivo. LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2 3 receptor (mGlu2 3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM.

LY2979165 (mGlu2 agonist) 是 mGluR2 的正构激动剂，可用于作为抗抑郁药的研究。

LY-2300559 是代谢型谷氨酸受体 2 (mGluR2) 的激动剂，可用于偏头痛治疗的研究。

JNJ42153605是一种代谢型谷氨酸2 (mGlu2) 受体的正变构调节剂，EC50值为17 nM。

LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2 3 receptor agonist.